Evidence map›Paper›PMID 26890609›Full record

ArticlePLoS neglected tropical diseases2016

What Makes a Bacterial Species Pathogenic?:Comparative Genomic Analysis of the Genus Leptospira.

Derrick E Fouts, Michael A Matthias, Haritha Adhikarla, Ben Adler, Luciane Amorim-Santos, Douglas E Berg, Dieter Bulach, Alejandro Buschiazzo, Yung-Fu Chang, Renee L Galloway and 19 more

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS neglected tropical diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 4 pooled it
33.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 4 syntheses or guidelines pooled it, 309 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Isolation, Purification, and Characterization of Leptophages.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  18. Detection of pathogenicOne health (Amsterdam, Netherlands) · 2025
    Article
  19. Article
  20. Review

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 11 countries.

Derrick E FoutsJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Michael A MatthiasDivision of Infectious Diseases, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California, United States of America.
Haritha AdhikarlaDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
Ben AdlerAustralian Research Council Centre of Excellence in Structural and Functional Microbial Genomics, Department of Microbiology, Monash University, Clayton, Australia.
Luciane Amorim-SantosDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
Douglas E BergDivision of Infectious Diseases, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California, United States of America.
Dieter BulachVictorian Bioinformatics Consortium, Monash University, Clayton, Victoria, Australia.
Alejandro BuschiazzoInstitut Pasteur de Montevideo, Laboratory of Molecular and Structural Microbiology, Montevideo, Uruguay.
Yung-Fu ChangDepartment of Population Medicine & Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Renee L GallowayCenters for Disease Control and Prevention (DHHS, CDC, OID, NCEZID, DHCPP, BSPB), Atlanta, Georgia, United States of America.
David A HaakeVA Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.
Daniel H HaftJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Rudy HartskeerlWHO/FAO/OIE and National Collaborating Centre for Reference and Research on Leptospirosis, KIT Biomedical Research, Royal Tropical Institute (KIT), Amsterdam, The Netherlands.
Albert I KoDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
Paul N LevettGovernment of Saskatchewan, Disease Control Laboratory Regina, Canada.
James MatsunagaVA Greater Los Angeles Healthcare System, Los Angeles, California, United States of America.
Ariel E MechalyInstitut Pasteur de Montevideo, Laboratory of Molecular and Structural Microbiology, Montevideo, Uruguay.
Jonathan M MonkDepartment of Bioengineering, University of California, San Diego, La Jolla, California, United States of America.
Ana L T NascimentoCentro de Biotecnologia, Instituto Butantan, São Paulo, SP, Brazil.
Karen E NelsonJ. Craig Venter Institute, Rockville, Maryland, United States of America.
Bernhard PalssonDepartment of Bioengineering, University of California, San Diego, La Jolla, California, United States of America.
Sharon J PeacockDepartment of Medicine, University of Cambridge, Cambridge, United Kingdom.
Mathieu PicardeauInstitut Pasteur, Biology of Spirochetes Unit, National Reference Centre and WHO Collaborating Center for Leptospirosis, Paris, France.
Jessica N RicaldiInstituto de Medicina Tropical Alexander von Humboldt; Facultad de Medicina Alberto Hurtado, Universidd Peruana Cayetano Heredia, Lima, Peru.
Janjira ThaipandungpanitFaculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Elsio A WunderDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, United States of America.
X Frank YangDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Jun-Jie ZhangDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Joseph M VinetzDivision of Infectious Diseases, Department of Medicine, University of California San Diego School of Medicine, La Jolla, California, United States of America.
University of California, San Diego · USJ. Craig Venter Institute · USFundação Oswaldo Cruz · BRInstitut Pasteur · FRUniversidad Peruana Cayetano Heredia · PEYale University · USIndiana University – Purdue University Indianapolis · USIndiana University School of MedicineInstituto Butantan · BRInstitut Pasteur de Montevideo · UYMahidol University · THMelbourne Bioinformatics · AUMonash University · AUNational Center for Emerging and Zoonotic Infectious Diseases · USNew York State College of Veterinary Medicine · USRoyal Tropical Institute · NLSaskatchewan Disease Control Laboratory · CAUniversity of California, Los Angeles · USUniversity of Cambridge · GBVA Greater Los Angeles Healthcare System · US

Funding

Research Mentoring and Building Capacity of underrepresented Minority Research Scientists in India.D43TW010540 · FIC · YALE UNIVERSITY · PI MICHELE BARRY, Eva Harris · 2017 to 2026
$15.5M
Naturally-Acquired and Vaccine-Mediated Immunity to LeptospirosisR01AI121207 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG, REIS, MITERMAYER GALVAO DOS · 2016 to 2020
$6.4M
Global Health Fellows and Scholars Research TrainingR25TW009338 · FIC · UNIVERSITY OF CALIFORNIA BERKELEY · PI BARRY, MICHELE, KO, ALBERT ICKSANG · 2012 to 2016
$5.2M
Outer Membrane Proteins of Pathogenic Leptospira SpeciesR01AI034431 · NIAID · BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE · PI GOMES-SOLECKI, MARIA, HAAKE, DAVID A · 2003 to 2015
$4.1M
Disease Determinants of Urban LeptospirosisU01AI088752 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG · 2010 to 2014
$3.6M
Predicting Risk of Human Leptospiros by Environmental SurveillanceR01AI108276 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2013 to 2017
$3.6M
Translational Research Development for Endemic Infectious Diseases of AmazoniaD43TW007120 · FIC · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2004 to 2020
$3.0M
Natural History of Urban LeptospirosisR01AI052473 · NIAID · YALE UNIVERSITY · PI KO, ALBERT ICKSANG · 2003 to 2013
$2.8M
Ecoepidemiology of leptospirosis in the urban slums of BrazilR01TW009504 · FIC · YALE UNIVERSITY · PI BEGON, MICHAEL, CHILDS, JAMES EMORY · 2012 to 2016
$2.2M
Draft Scientific ComponentU19AI115658 · NIAID · YALE UNIVERSITY · PI AGAMPODI, SUNETH BUDDHIKA · 2015 to 2019
$1.9M
Patient-Oriented Research in Tropical Infectious DiseasesK24AI068903 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VINETZ, JOSEPH M. · 2006 to 2015
$1.5M
B12 Autotrophy as a Virulence Mechanism in Infectious LeptospiraR21AI115273 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MATTHIAS, MICHAEL A · 2015 to 2016
$426k
BLRD VA I01 BX002003FIC NIH HHS D43 TW007120FIC NIH HHS D43TW007120FIC NIH HHS D43 TW010540FIC NIH HHS R01 TW009504FIC NIH HHS R01TW009504FIC NIH HHS R25 TW009338FIC NIH HHS R25TW009338NIAID NIH HHS HHSN272200900007CNIAID NIH HHS K24 AI068903NIAID NIH HHS K24AI068903NIAID NIH HHS R01 AI034431NIAID NIH HHS R01 AI052473NIAID NIH HHS R01AI052473NIAID NIH HHS R01 AI108276NIAID NIH HHS R01AI108276NIAID NIH HHS R01 AI121207NIAID NIH HHS R01AI121207NIAID NIH HHS R21 AI115273NIAID NIH HHS R21AI115273NIAID NIH HHS U01 AI088752NIAID NIH HHS U01AI088752NIAID NIH HHS U19 AI115658NIAID NIH HHS U19AI115658
6 · The paper itself

Abstract

Leptospirosis, caused by spirochetes of the genus Leptospira, is a globally widespread, neglected and emerging zoonotic disease. While whole genome analysis of individual pathogenic, intermediately pathogenic and saprophytic Leptospira species has been reported, comprehensive cross-species genomic comparison of all known species of infectious and non-infectious Leptospira, with the goal of identifying genes related to pathogenesis and mammalian host adaptation, remains a key gap in the field. Infectious Leptospira, comprised of pathogenic and intermediately pathogenic Leptospira, evolutionarily diverged from non-infectious, saprophytic Leptospira, as demonstrated by the following computational biology analyses: 1) the definitive taxonomy and evolutionary relatedness among all known Leptospira species; 2) genomically-predicted metabolic reconstructions that indicate novel adaptation of infectious Leptospira to mammals, including sialic acid biosynthesis, pathogen-specific porphyrin metabolism and the first-time demonstration of cobalamin (B12) autotrophy as a bacterial virulence factor; 3) CRISPR/Cas systems demonstrated only to be present in pathogenic Leptospira, suggesting a potential mechanism for this clade's refractoriness to gene targeting; 4) finding Leptospira pathogen-specific specialized protein secretion systems; 5) novel virulence-related genes/gene families such as the Virulence Modifying (VM) (PF07598 paralogs) proteins and pathogen-specific adhesins; 6) discovery of novel, pathogen-specific protein modification and secretion mechanisms including unique lipoprotein signal peptide motifs, Sec-independent twin arginine protein secretion motifs, and the absence of certain canonical signal recognition particle proteins from all Leptospira; and 7) and demonstration of infectious Leptospira-specific signal-responsive gene expression, motility and chemotaxis systems. By identifying large scale changes in infectious (pathogenic and intermediately pathogenic) vs. non-infectious Leptospira, this work provides new insights into the evolution of a genus of bacterial pathogens. This work will be a comprehensive roadmap for understanding leptospirosis pathogenesis. More generally, it provides new insights into mechanisms by which bacterial pathogens adapt to mammalian hosts.

Indexed as

Genome, BacterialAnimalsBacterial ProteinsBacterial Secretion SystemsBase SequenceEvolution, MolecularGenomicsHumansLeptospiraLeptospirosisMolecular Sequence DataPhylogenyProtein Sorting SignalsVirulenceBacterial ProteinsBacterial Secretion SystemsProtein Sorting Signals

Identifiers

PMID26890609
PMCPMC4758666
OpenAlexW2286459095

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.